Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in TBPH — Theravance Biopharma, Inc.

CIK 1423053 MIAMI, FL
Back to TBPH Full portfolio

Position in TBPH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,397,256
-$3,012,690 QoQ
Shares Held
86,091
-63.5% QoQ
Ownership
0.167%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Derivatives in TBPH

reported options exposure · as of Mar 31, 2026
CallValue
$322,977
CallShares
19,900
PutValue
$198,006
PutShares
12,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,531,311,130 across 373 Biotechnology names. TBPH ranks #204 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260
8 ARGX
Argenx SE
 219,126 $160,016,761

All Filings in TBPH

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $198,006 12,200
2026-03-31 $1,397,256 86,091
2026-03-31 $322,977 19,900
2025-12-31 $4,409,946 235,700
2025-09-30 $742,657 50,867
2025-06-30 $5,353,200 485,331
2025-03-31 $3,917,671 438,709
2025-03-31 $6,251 700
2025-03-31 $12,502 1,400
2024-12-31 $2,960,592 314,622
2024-12-31 $5,646 600
2024-12-31 $2,823 300
2024-09-30 $9,672 1,200
2024-09-30 $1,612 200
2024-09-30 $1,890,521 234,556
2024-06-30 $2,069,238 244,014
2024-06-30 $26,288 3,100
2024-06-30 $117,872 13,900
2024-03-31 $20,631 2,300
2024-03-31 $1,038,796 115,808
2024-03-31 $12,558 1,400
2023-12-31 $50,580 4,500
2023-12-31 $1,687,371 150,122
2023-12-31 $1,124 100
2023-09-30 $316,884 36,719
2023-09-30 $60,410 7,000
2023-06-30 $111,780 10,800
2023-06-30 $838,525 81,017
2023-06-30 $51,750 5,000
2023-03-31 $92,225 8,500
2023-03-31 $320,075 29,500
2023-03-31 $711,498 65,576
2022-12-31 $372,504 33,200
2022-12-31 $545,292 48,600
2022-12-31 $946,361 84,346
2022-09-30 $2,539,531 250,447
2022-09-30 $182,520 18,000
2022-06-30 $144,126 15,908
2022-06-30 $90,600 10,000
2022-03-31 $158,150 16,543
2022-03-31 $212,232 22,200
2021-12-31 $117,637 10,646
2021-12-31 $349,180 31,600
2021-09-30 $158,360 21,400
2021-09-30 $2,359,120 318,800
2021-03-31 $220,428 10,800
2020-09-30 $2,199,298 148,752
2020-06-30 $3,588,891 170,981
2020-03-31 $472,691 20,454

Report a Problem

Category
Description
Email (optional, for follow-up)